A proof-of-concept study: mirabegron, a new therapy for overactive bladder.
Chapple CR, Amarenco G, López Aramburu MA, Everaert K, Liehne J, Lucas M, Vik V, Ridder A, Snijder R, Yamaguchi O; BLOSSOM Investigator Group.
Chapple CR, et al. Among authors: everaert k.
Neurourol Urodyn. 2013 Nov;32(8):1116-22. doi: 10.1002/nau.22373. Epub 2013 Feb 19.
Neurourol Urodyn. 2013.
PMID: 23424164
Clinical Trial.